Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma from the phase 2 primo trial: Dose optimization efficacy update and expansion phase initial results Meeting Abstract
| Authors: | Pro, B.; Brammer, J. E.; Casulo, C.; Jacobsen, E.; Mead, M.; Mehta-Shah, N.; Zain, J. M.; Zinzani, P. L.; Lustgarten, S.; Youssoufian, H.; Horwitz, S. M. |
| Abstract Title: | Duvelisib in patients with relapsed/refractory peripheral T-cell lymphoma from the phase 2 primo trial: Dose optimization efficacy update and expansion phase initial results |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205605236 |
| DOI: | 10.1182/blood-2020-140412 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 38 -- Source: Wos |
